Microglial pannexin-1 channel activation is a spinal determinant of joint pain
Open Access
- 3 August 2018
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 4 (8) , eaas9846
Abstract
Chronic joint pain such as mechanical allodynia is the most debilitating symptom of arthritis, yet effective therapies are lacking. We identify the pannexin-1 (Panx1) channel as a therapeutic target for alleviating mechanical allodynia, a cardinal sign of arthritis. In rats, joint pain caused by intra-articular injection of monosodium iodoacetate (MIA) was associated with spinal adenosine 5′-triphosphate (ATP) release and a microglia-specific up-regulation of P2X7 receptors (P2X7Rs). Blockade of P2X7R or ablation of spinal microglia prevented and reversed mechanical allodynia. P2X7Rs drive Panx1 channel activation, and in rats with mechanical allodynia, Panx1 function was increased in spinal microglia. Specifically, microglial Panx1-mediated release of the proinflammatory cytokine interleukin-1β (IL-1β) induced mechanical allodynia in the MIA-injected hindlimb. Intrathecal administration of the Panx1-blocking peptide 10panx suppressed the aberrant discharge of spinal laminae I-II neurons evoked by innocuous mechanical hindpaw stimulation in arthritic rats. Furthermore, mice with a microglia-specific genetic deletion of Panx1 were protected from developing mechanical allodynia. Treatment with probenecid, a clinically used broad-spectrum Panx1 blocker, resulted in a striking attenuation of MIA-induced mechanical allodynia and normalized responses in the dynamic weight-bearing test, without affecting acute nociception. Probenecid reversal of mechanical allodynia was also observed in rats 13 weeks after anterior cruciate ligament transection, a model of posttraumatic osteoarthritis. Thus, Panx1-targeted therapy is a new mechanistic approach for alleviating joint pain.Keywords
Funding Information
- Canadian Institutes of Health Research (MOP133523)
- Natural Sciences and Engineering Research Council of Canada (RGPIN418299)
This publication has 48 references indexed in Scilit:
- Anoxia-Induced NMDA Receptor Activation Opens Pannexin Channels via Src Family KinasesThe Journal of Neuroscience, 2012
- Peripheral inflammatory disease associated with centrally activated IL-1 system in humans and miceProceedings of the National Academy of Sciences, 2012
- A potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseasesExpert Opinion on Investigational Drugs, 2011
- The Contribution of Spinal Glial Cells to Chronic Pain Behaviour in the Monosodium Iodoacetate Model of Osteoarthritic PainMolecular Pain, 2011
- Effect of interleukin-1β on spinal cord nociceptive transmission of normal and monoarthritic rats after disruption of glial functionArthritis Research & Therapy, 2009
- Behavioural and Electrophysiological Characterisation of Experimentally Induced Osteoarthritis and Neuropathy in C57Bl/6 MiceMolecular Pain, 2009
- Probenecid, a gout remedy, inhibits pannexin 1 channelsAmerican Journal of Physiology-Cell Physiology, 2008
- Long-Term Actions of Interleukin-1β on Delay and Tonic Firing Neurons in Rat Superficial Dorsal Horn and Their Relevance to Central SensitizationMolecular Pain, 2008
- Pannexin‐1 mediates large pore formation and interleukin‐1β release by the ATP‐gated P2X7 receptorThe EMBO Journal, 2006
- Trans-synaptic shift in anion gradient in spinal lamina I neurons as a mechanism of neuropathic painNature, 2003